Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/nanopublications.trig#NP855002.RASfD9g_vVmOs6fqts4fAl_KtxiKmgacLyLrgN4zX2HJY130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP855002.RASfD9g_vVmOs6fqts4fAl_KtxiKmgacLyLrgN4zX2HJY130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP855002.RASfD9g_vVmOs6fqts4fAl_KtxiKmgacLyLrgN4zX2HJY130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP855002.RASfD9g_vVmOs6fqts4fAl_KtxiKmgacLyLrgN4zX2HJY130_provenance.
- NP855002.RASfD9g_vVmOs6fqts4fAl_KtxiKmgacLyLrgN4zX2HJY130_assertion description "[When studying the relations between the most important clinicopathologic features of breast cancer and the mRNA expression level of both MBDs, we found that oestrogen receptor (OR)-positive breast cancer specimens contained higher levels of MeCP2 mRNA than did OR-negative cancers (P=0.005).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP855002.RASfD9g_vVmOs6fqts4fAl_KtxiKmgacLyLrgN4zX2HJY130_provenance.
- NP855002.RASfD9g_vVmOs6fqts4fAl_KtxiKmgacLyLrgN4zX2HJY130_assertion evidence source_evidence_literature NP855002.RASfD9g_vVmOs6fqts4fAl_KtxiKmgacLyLrgN4zX2HJY130_provenance.
- NP855002.RASfD9g_vVmOs6fqts4fAl_KtxiKmgacLyLrgN4zX2HJY130_assertion SIO_000772 14612906 NP855002.RASfD9g_vVmOs6fqts4fAl_KtxiKmgacLyLrgN4zX2HJY130_provenance.
- NP855002.RASfD9g_vVmOs6fqts4fAl_KtxiKmgacLyLrgN4zX2HJY130_assertion wasDerivedFrom befree-20140225 NP855002.RASfD9g_vVmOs6fqts4fAl_KtxiKmgacLyLrgN4zX2HJY130_provenance.
- NP855002.RASfD9g_vVmOs6fqts4fAl_KtxiKmgacLyLrgN4zX2HJY130_assertion wasGeneratedBy ECO_0000203 NP855002.RASfD9g_vVmOs6fqts4fAl_KtxiKmgacLyLrgN4zX2HJY130_provenance.
- befree-20140225 importedOn "2014-02-25" NP855002.RASfD9g_vVmOs6fqts4fAl_KtxiKmgacLyLrgN4zX2HJY130_provenance.